Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05227027
Other study ID # 19-29335
Secondary ID NCI-2021-07004P3
Status Completed
Phase N/A
First received
Last updated
Start date February 9, 2022
Est. completion date May 31, 2022

Study information

Verified date November 2023
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the effects of a video game embedded in a commercially available mobile application (app) for smoking cessation. Smokers are increasingly turning to mobile health apps for assistance with quitting smoking, and there is a critical need for strategies to engage app users to increase retention and efficacy. Video games are designed to increase users' motivation and engagement, which in turn may increase their exposure and adherence to a smoking cessation program. The hypothesis is that the game increases engagement, retention, and smoking abstinence rates compared with a core version of the app without the game. A two-arm individually randomized pilot trial of 500 adult smokers will test this hypothesis, comparing outcomes for participants randomized to receive the core app plus embedded game with participants randomized to receive the core app only. Primary outcomes relate to user engagement with the app. Secondary outcomes relate to user engagement, efficacy (smoking abstinence), and user satisfaction.


Description:

PRIMARY OBJECTIVES: I. Augment an existing smartphone cessation app for smoking cessation with a video game to increase user engagement. II. Test the feasibility, engagement, and early efficacy of the 'gamified' app, compared to one without gamification. OUTLINE: Participants are recruited through the Smoke Free smartphone app and randomized to 1 of 2 arms. ARM I: Participants receive an educational intervention through the Smoke Free application (core app) with the embedded video game module. Participants complete questionnaires and may undergo saliva sample collection, if they report being smoke-free on follow-up. ARM II: Participants receive an educational intervention through the Smoke Free application without the video game module (core app only). Participants complete questionnaires and may undergo saliva sample collection, if they report being smoke-free on follow-up.


Recruitment information / eligibility

Status Completed
Enrollment 500
Est. completion date May 31, 2022
Est. primary completion date May 31, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: 1. Provides electronic informed consent. 2. Male or female, aged 18 and older 3. Has downloaded and opened the Smoke Free app 4. A smoker of at least 1 cigarette per day 5. Plans to quit smoking within the next 7 days 6. Speaks, reads, and writes English 7. Lives in the United States Exclusion criteria: None

Study Design


Related Conditions & MeSH terms

  • Cigarette Smoking-Related Carcinoma

Intervention

Behavioral:
Game Module
Receive access to the the game module through the free, 'Smoke Free' smartphone application
Smoke Free smartphone application
Receive educational intervention through the free 'Smoke Free' smartphone application (core version of the app)

Locations

Country Name City State
United States University of California San Francisco San Francisco California

Sponsors (5)

Lead Sponsor Collaborator
University of California, San Francisco Johns Hopkins University, National Cancer Institute (NCI), National Institute on Aging (NIA), University of California, Berkeley

Country where clinical trial is conducted

United States, 

References & Publications (1)

White JS, Salem MK, Toussaert S, Westmaas JL, Raiff BR, Crane D, Warrender E, Lyles C, Abroms L, Thrul J. Developing a Game (Inner Dragon) Within a Leading Smartphone App for Smoking Cessation: Design and Feasibility Evaluation Study. JMIR Serious Games. 2023 Aug 11;11:e46602. doi: 10.2196/46602. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Biochemically Verified 7-day Point-prevalence Abstinence at 2 Months Proportion of participants who who self-report having abstained for the prior 7 days during the 2-month follow-up assessment, verified by saliva cotinine test, assuming missing = smoking. Averaged by study group. Recoded to 0 if the person reported having smoked during the same 7-day window during repeated measurement of daily smoking in the app. 56 days after participant's selected quit date (56 to 63 days after enrollment)
Other Biochemically Verified 30-day Point-prevalence Abstinence at 2 Months Proportion of participants who who self-report having abstained for the prior 30 days during the 2-month follow-up assessment, verified by saliva cotinine test, assuming missing = smoking. Averaged by study group. Recoded to 0 if the person reported having smoked during the same 30-day window during repeated measurement of daily smoking in the app. 56 days after participant's selected quit date (56 to 63 days after enrollment)
Other Repeated 1-day Point-prevalence Smoking Abstinence Proportion of days in which participants self-report having abstained in the last 24 hours, collected via a pop-up box that appears the first time each day a participant opens the app. Averaged by study group. During the 56 days after participant's selected quit date
Other Program Adherence (Index of Core Feature Use) Number of non-game (core app) activities completed in the app by activity type: passively collected by the app to assess number of times the participant completed the following activity types: reported a craving, recorded a diary, completed a mission, read a tip, used the chatbot. Enrollment through 56 days after participant's selected quit date (56 to 63 days total)
Other Gifts Unlocked (Intervention Group Only) Number of in-game gifts unlocked during the study period (intervention group only); a summary measure of intensity of engagement (dose of treatment) of the app; passively collected by the app. Enrollment through 56 days after participant's selected quit date (56 to 63 days total)
Other Game Activities (Intervention Group Only) Number of game activities completed in the app by activity type; passively collected by the app to assess number of times the participant completed the following activity types: navigated to the game dashboard, completed each pet care activity (breathing exercise, feeding, washing, memory mini-game), visited the park, entered the dragon guide. Enrollment through 56 days after participant's selected quit date (56 to 63 days total)
Other Recommends App to Friend Rating of whether would recommend assigned app to a friend on a 5-point Likert scale from "Not at all" (1) to "Extremely" (5), assessed in the 2-month follow-up questionnaire. The measure is averaged by study group. 56 days after participant's selected quit date (56 to 63 days after enrollment)
Other Motivation to Quit Motivation to quit, reported on a 10-point scale from not at all motivated (0) to very unmotivated (10) and assessed in the 2-month follow-up. 56 days after participant's selected quit date (56 to 63 days after enrollment)
Other Digital Therapeutic Alliance The measure includes items from the Bonding and Confidence subscales from the Mobile Agnew Relationship Measure, a scale of digital therapeutic alliance. Two items from each of the Bonding and Confidence subscales were included. Each item was asked on a 4-point Likert scale from strongly disagree (1) to strongly agree (4). The subscale items were combined to give a total possible score of 16 and a range of 4 (low alliance) to 16 (high alliance). The measure is averaged by study group. Assessed in the 2-month follow-up. 56 days after participant's selected quit date (56 to 63 days after enrollment)
Primary Number of Unique App Sessions Number of times the app was opened; passively collected by the app and averaged in analysis to calculate mean number of app opens by study group over the study period. A new session is defined as use of the app after at least 30 minutes of inactivity. Enrollment through 56 days after participant's selected quit date (56 to 63 days total)
Primary Minutes of App Usage Per Session Passively collected by the app and averaged in analysis among those with a session to calculate mean number of minutes of usage per session by study group. Enrollment through 56 days after participant's selected quit date (56 to 63 days total)
Secondary Unique Days With at Least One App Session Number of unique days with at least one app session, passively collected by the app and averaged by study group. Enrollment through 56 days after participant's selected quit date (56 to 63 days total)
Secondary Self-reported 7-day Point-prevalence Abstinence at 2 Months Proportion of participants who self-report having abstained for the prior 7 days during the 2-month follow-up assessment, assuming missing = smoking. 56 days after participant's selected quit date (56 to 63 days after enrollment)
Secondary Self-reported 30-day Point-prevalence Abstinence at 2 Months Proportion of participants who who self-report having abstained for the prior 30 days during the 2-month follow-up assessment, assuming missing = smoking. 56 days after participant's selected quit date (56 to 63 days after enrollment)
Secondary Satisfaction With App Rating of satisfaction with assigned app on a 5-point Likert scale from "Not at all" (1) to "Extremely" (5), assessed in the 2-month follow-up questionnaire. The measure is averaged by study group. 56 days after participant's selected quit date (56 to 63 days after enrollment)
Secondary Satisfaction With Game (Intervention Group Only) Rating of satisfaction with the game on a 5-point Likert scale from "Not at all" (1) to "Extremely" (5), assessed in the 2-month follow-up questionnaire. The measure is averaged for the intervention group. 56 days after participant's selected quit date (56 to 63 days after enrollment)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06038526 - Evaluation of Canakinumab in High-Risk Former-Smokers Phase 2
Recruiting NCT05121051 - Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers Phase 2
Not yet recruiting NCT06386432 - EQQUAL-NM for the Promotion of Smoking Cessation in Sexual and Gender Minority Young Adults in New Mexico N/A
Active, not recruiting NCT02964182 - Very Low Nicotine Content Cigarettes and E-Cigarettes in Promoting Smoking Cessation in Daily and Intermittent Cigarette Smokers N/A
Completed NCT04510077 - SmartQuit Program for Smoking Cessation N/A
Recruiting NCT06230159 - Evaluating the Impact of Synthetic Cooling Agents in Combustible Cigarettes on Smoking Perceptions and Use N/A
Completed NCT04525222 - mHealth Mood Management Tool (Actify) to Improve Population-Level Smoking Cessation Phase 1
Completed NCT05455086 - Free-Base Nicotine or Nicotine Salt e-Liquids in Current E-Cigarette Smokers, PeloPET Study N/A
Recruiting NCT06010355 - Culturally Tailored Educational Video to Promote Lung Cancer Screening in Vulnerable Communities N/A
Completed NCT05236894 - Appeal of Nicotine Pouches Versus Cigarettes in the Ohio Appalachia Population Early Phase 1
Recruiting NCT05825001 - Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette Smokers N/A
Not yet recruiting NCT06213532 - CONNECTing to LungCare N/A
Recruiting NCT03856515 - Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes N/A
Completed NCT03480373 - Electronic Cigarette Use During Pregnancy
Not yet recruiting NCT06055231 - PK/PD of Vaping THC-containing Liquids vs. Smoked Cannabis Phase 1
Active, not recruiting NCT04308759 - An Innovative Conversational Agent (Quitbot) for Smoking Cessation Phase 3
Active, not recruiting NCT04972513 - Impact of E-cigarette Use on the Body
Withdrawn NCT05024955 - Evaluating Shared Decision-Making for Lung Cancer Screening Among Chinese Populations in the United States
Completed NCT04502524 - Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans Phase 1
Completed NCT03402230 - Broccoli Sprout/Broccoli Seed Extract Supplement in Decreasing Toxicity in Heavy Smokers Early Phase 1